MBF: Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented
What it covers
A shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits movement in one or more planes. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral component made of alloys such as cobalt-chromium-molybdenum (Co-Cr-Mo) and titanium-aluminum-vanadium (Ti-6Al-4V) alloys, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, or a combination of an articulating ultra-high molecular weight bearing surface fixed in a metal shell made of alloys such as Co-Cr-Mo and Ti-6Al-4V. The humeral component and glenoid backing have a porous coating made of, in the case of Co-Cr-Mo components, beads of the same alloy or commercially pure titanium powder, and in the case of Ti-6Al-4V components, beads or fibers of commercially pure titanium or Ti-6Al-4V alloy, or commercially pure titanium powder. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. This generic type of device is designed to achieve biological fixation to bone without the use of bone cement.
The identification in 21 CFR 888.3670, shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis. FDA gives MBF no definition of its own, so the regulation’s describes it.
FDA flags MBF devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K253592 | Zimmer Biomet Reverse Shoulder Prosthesis (Alliance Humeral Bearings, Identity Humeral Trays, Comprehensive Reverse Humeral Trays, Comprehensive Reverse 32mm Glenospheres and Adapter) | Zimmer, Inc. | Apr 13, 2026 | Traditional |
| K251098 | Identity Revision Humeral Stems | Zimmer, Inc. | Aug 11, 2025 | Traditional |
| K250848 | Identity Shoulder System | Zimmer, Inc. | Jul 2, 2025 | Traditional |
| K240876 | Identity Shoulder System | Zimmer, Inc. | Jun 12, 2024 | Traditional |
| K233712 | PRIMA Humeral System; PRIMA TT Glenoid | Lima Corporate S.P.A. | Jan 11, 2024 | Traditional |
| K231099 | SMR Hybrid Glenoid System | Lima Corporate S.P.A. | Dec 21, 2023 | Traditional |
| K230831 | INHANCE Shoulder System Convertible Glenoid Inserts, INHANCE Convertible Glenoid | Depuy Ireland UC | Nov 13, 2023 | Traditional |
| K231516 | INHANCE Shoulder System, Sterile Single Use Instrumentation | Depuy Ireland UC | Jul 21, 2023 | Traditional |
| K223876 | SMR Shoulder System | Lima Corporate S.P.A. | Feb 3, 2023 | Traditional |
| K222427 | PRIMA TT Glenoid | Lima Corporate S.P.A. | Oct 6, 2022 | Traditional |
Clearances by year
25 MBF 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 147 |
| 2025 | 2 | 114 |
| 2024 | 2 | 64 |
| 2023 | 4 | 144 |
| 2022 | 4 | 164 |
| 2021 | 1 | 245 |
| 2020 | 2 | 262 |
| 2019 | 2 | 56 |
| 2018 | 1 | 309 |
| 2017 | 2 | 232 |
| 2014 | 1 | 208 |
| 2013 | 1 | 201 |
| 2012 | 2 | 132 |
Who submits
10 applicants cleared a MBF device since 2011. 52% of the clearances went to applicants in United States, then Italy (32%), Ireland (12%) and France (4%). By type: Traditional 96% and Special 4%.
| Applicant | Clearances since 2011 |
|---|---|
| Lima Corporate S.P.A. | 8 |
| Zimmer, Inc. | 5 |
| Depuy Ireland UC | 3 |
| Biomet Manufacturing Corp | 2 |
| Biomet, Inc. | 2 |
| Biomet Manufactuting Corp. | 1 |
| Biomet Orthopedics, LLC | 1 |
| Fournitures Hospitalieres Industrie | 1 |
How FDA classifies it
Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance: Shoulder Joint Metal/Polymer/Metal Nonconstrained or Semi-Constrained Porous-Coated Uncemented Prosthesis.”
From 21 CFR 888.3670. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 888.3670 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MBF clearances declared.
Ask about MBF
Questions about MBF
What is FDA product code MBF?
Product code MBF, “Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3670 (shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 37 clearances under MBF, 25 of them since 2011.
How many 510(k) clearances are there under MBF?
FDA’s 510(k) database listed 37 clearances under MBF as of Oct 29, 2026, 25 of them decided since 2011; the most recent decision was Apr 13, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MBF 510(k)?
For the 3 MBF clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 123 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MBF clearances?
Since 2011: Lima Corporate S.P.A. (8), Zimmer, Inc. (5), Depuy Ireland UC (3), Biomet Manufacturing Corp (2) and Biomet, Inc. (2). 10 applicants have cleared a MBF device in that time.